uniQure (QURE) Revenue (2016 - 2026)

uniQure (QURE) posted quarterly Revenue of $5.8 million for Q2 2026, up 11.0% year-over-year from $5.3 million in Q2 2025, and up 63.98% quarter-over-quarter from $3.6 million in Q1 2026.

uniQure (QURE) Revenue (2016 - 2026) Analysis & Trends

uniQure's Revenue history runs 11 years deep, the most recent figure standing at $5.8 million for Q2 2026.

  • In Q2 2026, Revenue rose 11.0% year-over-year to $5.8 million; the TTM figure through Jun 2026 stood at $18.7 million (up 30.24% YoY), while the FY2025 annual figure was $16.1 million, down 40.64% from the prior year.
  • Revenue for Q2 2026 stood at $5.8 million, up from $3.6 million in the prior quarter.
  • The five-year high for Revenue was $102.7 million in Q4 2022, with the low at $497000.0 in Q2 2022.
  • The 5-year median for Revenue is $4.5 million (2024), against an average of $9.7 million.
  • The sharpest annual moves came in 2022 and 2023: Revenue tumbled 99.89% in 2022, then surged 387.32% in 2023.
  • uniQure's Revenue stood at $102.7 million in 2022, then plunged by 93.49% to $6.7 million in 2023, then decreased by 21.95% to $5.2 million in 2024, then grew by 6.65% to $5.6 million in 2025, then climbed by 4.9% to $5.8 million in 2026.
  • Business Quant data shows QURE's Revenue at $5.8 million in Q2 2026, $3.6 million in Q1 2026, and $5.6 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.56 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.71 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 3,001.92
7 Royalty Pharma 33.72 Bn 35.84 Bn - 674.14 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.29 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 425.49 Mn
10 uniQure 3.37 Bn 3.37 Bn 5.49 Mn 5.84 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 5.84 Mn
Mar 31, 2026 3.56 Mn
Dec 31, 2025 5.57 Mn
Sep 30, 2025 3.70 Mn
Jun 30, 2025 5.26 Mn
Mar 31, 2025 1.57 Mn
Dec 31, 2024 5.22 Mn
Sep 30, 2024 2.29 Mn
Jun 30, 2024 11.13 Mn
Mar 31, 2024 8.49 Mn
Dec 31, 2023 6.69 Mn
Sep 30, 2023 1.41 Mn
Jun 30, 2023 2.42 Mn
Mar 31, 2023 5.33 Mn
Dec 31, 2022 102.75 Mn
Sep 30, 2022 1.45 Mn
Jun 30, 2022 497,000.00
Mar 31, 2022 1.79 Mn
Dec 31, 2021 57.69 Mn
Sep 30, 2021 1.99 Mn